Figueredo R - Search Results

1

BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.

Rytelewski M, Tong JG, Buensuceso A, Leong HS, Maleki Vareki S, Figueredo R, Di Cresce C, Wu SY, Herbrich SM, Baggerly KA, Romanow L, Shepherd T, Deroo BJ, Sood AK, Chambers AF, Vincent M, Ferguson PJ, Koropatnick J. Rytelewski M, et al. Among authors: figueredo r. Mol Oncol. 2014 Dec;8(8):1429-40. doi: 10.1016/j.molonc.2014.05.017. Epub 2014 Jun 6. Mol Oncol. 2014. PMID: 24974076 Free PMC article.

2

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".

Rytelewski M, Ferguson PJ, Maleki Vareki S, Figueredo R, Vincent M, Koropatnick J. Rytelewski M, et al. Among authors: figueredo r. Mol Ther Nucleic Acids. 2013 Mar 12;2(3):e78. doi: 10.1038/mtna.2013.7. Mol Ther Nucleic Acids. 2013. PMID: 23481354 Free PMC article.

3

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin.

Maleki Vareki S, Rytelewski M, Figueredo R, Chen D, Ferguson PJ, Vincent M, Min W, Zheng X, Koropatnick J. Maleki Vareki S, et al. Among authors: figueredo r. Oncotarget. 2014 May 15;5(9):2778-91. doi: 10.18632/oncotarget.1916. Oncotarget. 2014. PMID: 24784564 Free PMC article.

4

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2.

Rytelewski M, Maleki Vareki S, Mangala LS, Romanow L, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Figueredo R, Ferguson PJ, Vincent M, Sood AK, Koropatnick JD. Rytelewski M, et al. Among authors: figueredo r. Oncotarget. 2016 Apr 12;7(15):20825-39. doi: 10.18632/oncotarget.7883. Oncotarget. 2016. PMID: 26959114 Free PMC article.

5

Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.

Di Cresce C, Figueredo R, Ferguson PJ, Vincent MD, Koropatnick J. Di Cresce C, et al. Among authors: figueredo r. J Pharmacol Exp Ther. 2011 Sep;338(3):952-63. doi: 10.1124/jpet.111.183178. Epub 2011 Jun 14. J Pharmacol Exp Ther. 2011. PMID: 21673071

6

ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.

Jason TL, Figueredo R, Ferguson PJ, Vincent MD, Berg RW, Koropatnick J. Jason TL, et al. Among authors: figueredo r. DNA Cell Biol. 2008 May;27(5):229-40. doi: 10.1089/dna.2007.0674. DNA Cell Biol. 2008. PMID: 18358073

7

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.

Di Cresce C, Figueredo R, Rytelewski M, Maleki Vareki S, Way C, Ferguson PJ, Vincent MD, Koropatnick J. Di Cresce C, et al. Among authors: figueredo r. Oncotarget. 2015 Sep 8;6(26):22397-409. doi: 10.18632/oncotarget.4272. Oncotarget. 2015. PMID: 26087398 Free PMC article.

8

Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan.

Ferguson PJ, Sykelyk A, Figueredo R, Koropatnick J. Ferguson PJ, et al. Among authors: figueredo r. Tumori. 2016 Jan-Feb;102(1):31-9. doi: 10.5301/tj.5000438. Epub 2015 Sep 30. Tumori. 2016. PMID: 26429639

9

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells.

Maleki Vareki S, Chen D, Di Cresce C, Ferguson PJ, Figueredo R, Pampillo M, Rytelewski M, Vincent M, Min W, Zheng X, Koropatnick J. Maleki Vareki S, et al. Among authors: figueredo r. PLoS One. 2015 Nov 18;10(11):e0143435. doi: 10.1371/journal.pone.0143435. eCollection 2015. PLoS One. 2015. PMID: 26579709 Free PMC article.

10

CD5 blockade enhances ex vivo CD8⁺ T cell activation and tumour cell cytotoxicity.

Alotaibi F, Rytelewski M, Figueredo R, Zareardalan R, Zhang M, Ferguson PJ, Maleki Vareki S, Najajreh Y, El-Hajjar M, Zheng X, Min WP, Koropatnick J. Alotaibi F, et al. Among authors: figueredo r. Eur J Immunol. 2020 May;50(5):695-704. doi: 10.1002/eji.201948309. Epub 2020 Feb 25. Eur J Immunol. 2020. PMID: 31943150 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page